Discriminatory Dissolution Testing
Discriminatory Dissolution Testing is a type of dissolution test method designed to distinguish small but critical changes in the manufacturing process or formulation of a drug product by detecting differences in dissolution performance that may impact bioavailability.
39
Publications
1.1K
Citations
158
Authors
46
Institutions
Publications per year
2017–2026
4
39
Hitesh S. Purohit, Niraj S. Trasi, Dajun Sun et al. · Journal of Pharmaceutical Sciences · 2017 · 68 citations
Erna Swanepoel, Wilna Liebenberg, Melgardt M. de Villiers · European Journal of Pharmaceutics and Biopharmaceutics · 2003 · 62 citations
1–5 of 39
158
3
h-index
Universidade Federal do Rio Grande do Sul, Brazil
2 publications · 25 citations
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 158
46
Universidade Federal do Rio Grande do Sul
Porto Alegre, Brazil
5 h-index
18 publications
348 citations
Universidade Estadual Paulista (Unesp)
São Paulo, Brazil
2 h-index
6 publications
198 citations

Universidade Federal do Rio de Janeiro
Rio de Janeiro, Brazil
2 h-index
7 publications
180 citations
Bristol-Myers Squibb (United States)
New York, United States
2 h-index
7 publications
77 citations

North-West University
Potchefstroom, South Africa
2 h-index
3 publications
161 citations
Hélio Alonso University
Rio de Janeiro, Brazil
1 h-index
1 publications
20 citations
United States Food and Drug Administration
Silver Spring, United States
1 h-index
4 publications
272 citations

Chongqing University
Chongqing, China
1 h-index
2 publications
50 citations
1–8 of 46
9 publications · 295 citations
9
h-index
7 publications · 208 citations
7
h-index
4 publications · 170 citations
4
h-index
3 publications · 34 citations
3
h-index
3 publications · 55 citations
3
h-index
1–5